| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/21/1998 | CN1171112A Amino acid nucleic acids |
| 01/21/1998 | CN1171109A Novel quinuclidine derivatives and medicinal composition thereof |
| 01/21/1998 | CN1171104A Aminotetrazole derivatives useful as nitric oxide synthase inhibotors |
| 01/21/1998 | CN1171100A High purity N-(4-£N,N-bis(2-iodoethyl) amino|-phenoscycarbonyl|-L-glutamic acid |
| 01/21/1998 | CN1171051A Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception |
| 01/21/1998 | CN1170719A Estrogenic agents |
| 01/21/1998 | CN1170606A Compositions having inhibitive activity against 5 alpha-reductase and antibacterial activity against propionibacterium acnes |
| 01/21/1998 | CN1170603A Separating method for sesamins |
| 01/21/1998 | CN1170516A Growth promotion feed for chickens and method |
| 01/21/1998 | CN1037101C 4-substituted 1, 2, 4-triazole derivatives, its preparing method and use thereof |
| 01/20/1998 | US5710275 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors |
| 01/20/1998 | US5710274 N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands |
| 01/20/1998 | US5710262 Nucleic acid encoding HB15 polypeptides |
| 01/20/1998 | US5710177 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair & nails |
| 01/20/1998 | US5710171 Anticancer and antitumor agents |
| 01/20/1998 | US5710169 Therapeutic heterocycles |
| 01/20/1998 | US5710167 Hydroxamic acid derivatives with tricyclic substitution for treating degenerative joint diseases |
| 01/20/1998 | US5710163 Benzo f!quinolinones |
| 01/20/1998 | US5710149 Piperazine derivatives as 5-ht antagonists |
| 01/20/1998 | US5710145 Protein kinase C inhibitor |
| 01/20/1998 | US5710142 Vitamin D analogues |
| 01/20/1998 | US5710140 Phenyl heterocycles as COX-2 inhibitors |
| 01/20/1998 | US5710139 Heterocyclic compounds |
| 01/20/1998 | US5709884 Process for conditioning substances |
| 01/20/1998 | US5709864 Cosmetic or pharmaceutical and particularly dermatological, composition containing an extract of tephrosia, particularly Tephrosia purpurea |
| 01/20/1998 | US5709863 Oleic acid, azelaic acid, pimelic acid, palmitic acid |
| 01/20/1998 | US5709858 To which they are capable of binding; specified amino acid sequences; medical diagnosis |
| 01/20/1998 | US5709853 Method of treatment of atopic disease |
| 01/20/1998 | US5709848 Photocleavable metal-chelating agents and compositions containing the same |
| 01/20/1998 | CA2059000C Fused-ring aryl substituted imidazoles |
| 01/19/1998 | CA2210613A1 N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use |
| 01/18/1998 | CA2195606A1 Method of increasing efficacy of cancer drugs |
| 01/15/1998 | WO1998001563A2 Adenovirus e4 proteins for inducing cell death |
| 01/15/1998 | WO1998001552A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001465A1 Neuroactive peptide |
| 01/15/1998 | WO1998001428A1 AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN |
| 01/15/1998 | WO1998001426A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 01/15/1998 | WO1998001150A1 Interleukin-8 as an antiviral and antitumor agent |
| 01/15/1998 | WO1998001143A1 Use of artichoke (cynara) extracts |
| 01/15/1998 | WO1998001128A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 01/15/1998 | WO1997032989A3 Recombinant aav vector-based transduction system and use of same |
| 01/15/1998 | CA2260295A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259957A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259573A1 Amidinoindoles, amidinoazoles, and analogs thereof as inhibitors of factor xa and of thrombin |
| 01/15/1998 | CA2259137A1 Neuroactive peptide |
| 01/15/1998 | CA2258697A1 Interleukin-8 as an antiviral and antitumor agent |
| 01/14/1998 | EP0818454A1 Benzimidazole derivatives with antihistaminic activity |
| 01/14/1998 | EP0818453A1 Benzothiophene compounds and methods of use |
| 01/14/1998 | EP0818449A1 2-(1H)-quinolone derivatives as antagonists of excitatory amino acids |
| 01/14/1998 | EP0818443A2 Mercaptoketones and mercaptoalcohols, a process for their preparation and their use as inhibitors of matrix metalloproteinases |
| 01/14/1998 | EP0818442A2 Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor |
| 01/14/1998 | EP0818200A1 Use of polysaccharide to stimulate desquamation of the skin and compositions containing it |
| 01/14/1998 | EP0817967A1 Insulin mimetic and enhancer assay |
| 01/14/1998 | EP0817846A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 01/14/1998 | EP0817845A1 Conditional expression system |
| 01/14/1998 | EP0817839A1 Human dnase |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817795A1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor |
| 01/14/1998 | EP0817791A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis |
| 01/14/1998 | EP0817787A1 Nitrogenous macrocyclic compounds |
| 01/14/1998 | EP0817782A1 Phenyl derivatives useful as endothelin receptor antagonists |
| 01/14/1998 | EP0817778A1 Reversible protease inhibitors |
| 01/14/1998 | EP0817772A1 Pyrrolidinyl hydroxamic acid compounds and their production process |
| 01/14/1998 | EP0817767A1 Bicyclic amine derivatives and their use as anti-psychotic agents |
| 01/14/1998 | EP0817646A2 Methods of treating inflammation and compositions therefor |
| 01/14/1998 | EP0817642A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS |
| 01/14/1998 | EP0817641A1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same |
| 01/14/1998 | EP0817638A2 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
| 01/14/1998 | EP0817637A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 01/14/1998 | EP0817630A1 Inhibitors of farnesyl-protein transferase |
| 01/14/1998 | EP0817629A1 Inhibitors of farnesyl-protein transferase |
| 01/14/1998 | EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/14/1998 | EP0817627A1 Protein kinase c inhibitors |
| 01/14/1998 | EP0817623A1 Medicaments for the selective treatment of tumour tissues |
| 01/14/1998 | EP0817622A1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application |
| 01/14/1998 | EP0719278B1 Androstenone derivative |
| 01/14/1998 | EP0708648A4 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
| 01/14/1998 | EP0674639B1 Azanoradamantanes |
| 01/14/1998 | EP0662950B1 Benzenealkanoic acids for cardiovascular diseases |
| 01/14/1998 | EP0660832B1 Serotonin receptor agents |
| 01/14/1998 | EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 01/14/1998 | EP0603301B1 Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
| 01/14/1998 | CN1170414A Human neutrophil elastase inhibitors |
| 01/14/1998 | CN1170405A Aryl-and hetaryl-sulfonamide derivatives, their perparation and their use as endothelin antagonists |
| 01/14/1998 | CN1170366A Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 01/14/1998 | CN1170362A Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
| 01/14/1998 | CN1170361A Therapeutic perparation for inhalation containing parathyroid hormone, PTH |
| 01/14/1998 | CN1169993A Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof |
| 01/14/1998 | CN1169992A Sulfur-containing heterocyclic brad-ykinin antagcnists, process for their preparation and their use |
| 01/14/1998 | CN1169987A Ortho-substituen benzoyl guanidine, its preparation, use and mecdicines containing it |
| 01/14/1998 | CN1036995C Imidazodiazepine, and its preparation and use |
| 01/14/1998 | CN1036993C Method for preparation aromatase inhigiting 4(5)-imidazoles |
| 01/13/1998 | US5708174 Heterocyclic-esters or -amides used as 5-HT4 receptor antagonists |
| 01/13/1998 | US5708173 Heterocyclic compounds |
| 01/13/1998 | US5708171 Imidazole derivatives for pharmaceutical use |
| 01/13/1998 | US5708034 Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 01/13/1998 | US5708024 Salts of 2- (2,6-dichlorophenyl)amine!phenylacetoxyacetic acid with organic basic cations |
| 01/13/1998 | US5708020 Arylalkyl(thio)amides |
| 01/13/1998 | US5708018 2-aminoindans as selective dopamine D3 ligands |
| 01/13/1998 | US5708016 Pseudopeptides derived from neurokinins |